Industry News
Research, Science & Manufacturer Updates
Vaccines Articles
The U.S. Food and Drug Administration(FDA) has granted exclusivity to Flublok influenza vaccine for a period of 12 years.
A new study shows that people who receive a shingles vaccine but still contract shingles have a lower risk of developing post-herpatic neuralgia (PHN).
In a first-in-people clinical trial, personalized tailor-made melanoma vaccines given to three patients with advanced melanoma appeared to increase the number and diversity of cancer-fighting T cells responding to the tumors.
At its annual meeting in June, the American Medical Association (AMA) adopted a new policy to seek more stringent state immunization requirements to allow exemptions only for medical reasons.
Three recent studies have found that interventions increase the rates of human papillomavirus (HPV) vaccination among teens and young women.
A new simulation study that evaluated the relationship between Guillain-Barré syndrome (GBS) risk and influenza vaccine and illness suggests that the vaccine reduces the risk for GBS.
Researchers investigated the role of one or more pertussis vaccinations in preventing pertussis-related deaths and risk markers for death among infants aged younger than 42 days.
According to the 2013 National HealthInterview Survey, the most recent report used by the Centers for Disease Control and Prevention (CDC), only 29.6 percent of adults ages 18 to 48 receive the flu vaccine, and that number increases to 46.5 percent for adults ages 50 to 64and 67.9 percent for adults over 68.
Scientists at Georgia Institute ofTechnology have developed a needle-free vaccine against measles.
Results from a human trial of GlaxoSmithKline’s Ebola vaccine show it is safe and generates an immune response.
In response to the national measles outbreak, the American Academy of Pediatrics has released updated measles guidelines on its website.
A recent study found no link between the measles vaccine and autism.